全球遠距手術市場－2026-2031年預測

全球遠距手術市場預計將從 2025 年的 145.21 億美元成長到 2031 年的 365.58 億美元，複合年成長率為 16.64%。

全球遠距手術市場融合了先進的機器人技術、通訊技術和外科手術科學，徹底模式轉移了複雜手術的實施方式。在對外科創新持續成長的需求、對更便利的專科醫療服務以及技術日趨成熟的推動下，該市場正經歷顯著擴張。遠端手術（也稱為果凍或遠端手術技術）利用先進的機器人系統和高清通訊網路，使外科醫生能夠為遠在異地的患者實施微創手術。

市場核心動態與關鍵成長要素

市場成長受多種相互關聯的強大因素所驅動。其中最重要的是各外科專科對微創手術日益成長的需求。患者和醫療服務提供者都希望獲得諸如切口更小、創傷更小、疤痕更少、住院時間更短以及康復更快等益處。遠距手術平台（主要是機器人輔助系統）的設計初衷正是為了促進這種手術方式，它們能夠提供傳統腹腔鏡手術難以完成的複雜微創技術所需的精準度、靈活性和可視性。

這與人們對機器人輔助手術日益成長的認知及其臨床療效的證實密不可分。外科醫生和醫療機構越來越意識到機器人輔助手術的技術優勢，例如手術精確度、防手震和更佳的人體工學設計。隨著臨床證據的不斷積累，機器人輔助手術的普及門檻正在降低，從而促進了基於現有基礎的下一代遠距手術平台的接受度。

此外，全球對先進醫療基礎設施投資的不斷增加，正在建立推廣應用所需的生態系統。部署遠端手術系統不僅需要對技術本身進行資本投入，還需要強大的數位基礎設施，包括高頻寬、低延遲的通訊網路和整合的醫院資訊系統。對手術室現代化和通訊能力的策略性投資將是市場滲透的關鍵驅動力。

遠距手術的強大驅動力在於其在醫療服務效率和可及性方面具有變革性的潛力。遠距手術有望克服地域障礙，將世界一流的外科專家帶到偏遠農村和醫療資源匱乏地區的患者身邊，無需他們奔波。這可以最佳化稀缺外科專家的利用，減少醫療服務的系統性延誤，並透過集中化的專家資源和更有效率的患者就診流程，為醫療系統節省大量成本。

市場區隔與競爭格局

市場按組件類型、應用、最終用戶和地區進行細分。主要細分市場包括機器人系統（資本設備）、相關儀器和配件，以及配套軟體和服務。最終用戶主要為大型醫院和教學醫院，門診手術中心也具有成長潛力。

競爭格局呈現出既有成熟的醫療機器人產業領導企業，也有創新新興參與企業的並存態勢。直覺外科公司（Intuitive Surgical Inc.）憑藉其達文西手術系統，開創並建立了機器人輔助微創手術市場，從而維持了其歷史優勢。其他主要醫療技術公司，例如美敦力公司（Medtronic，其Hugo平台）和捷邁生物（Zimmer Biomet，其ROSA系統），分別致力於推進專注於普通外科和整形外科/神經外科的競爭平台。研究機構和技術開發商，例如SRI國際，正在貢獻基礎性創新，探索下一代遠距手術概念。競爭的核心在於技術差異化、手術操作的多樣性、成本效益以及臨床訓練和支援體系的深度。

地理視角：北美主導潮流

北美在全球遠距手術市場保持主導地位。這項優勢源自於一系列結構性優勢：主要市場參與者和研究機構高度集中；醫療基礎設施完善，技術普及率高；醫療支出龐大；以及複雜但完善的報銷環境，為先進外科技術建立了成熟的報銷機制。該地區對外科創新和新型醫療設備早期應用的重視，鞏固了其作為關鍵市場和下一代系統試驗場的地位。

未來展望及戰略意義

遠端手術市場即將超越目前僅限於單一手術室內的機器人輔助手術模式。未來的發展將朝著真正的遠端手術邁進，而超可靠、低延遲的通訊網路（例如5G及未來技術）將為此提供有力支持。這將需要觸覺回饋技術的進步、用於決策支援和安全保障的增強型人工智慧以及強大的網路安全通訊協定。

對於產業相關人員，策略成功不僅取決於展現卓越的臨床療效，還取決於透過提高營運效率和擴大患者覆蓋範圍來展現顯著的經濟價值。建立嚴格的遠端手術監管路徑、實施標準化的培訓和認證通訊協定，以及確保系統與現有醫院工作流程的無縫整合，將是關鍵挑戰。隨著遠距手術技術從先進工具轉型為網路化醫療服務平台，它將重新定義外科手術的邊界，使專業、高品質的醫療介入在全球範圍內更加便捷和高效。

本報告的主要優勢：

• 深入分析：提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
• 競爭格局：了解全球主要企業的策略舉措，並了解透過正確的策略進入市場的可能性。
• 市場促進因素與未來趨勢：探索推動市場的動態因素和關鍵趨勢，以及它們將如何塑造未來的市場發展。
• 可操作的建議：利用這些見解，在動態環境中製定策略決策，發展新的業務流和收入來源。
• 受眾廣泛：對Start-Ups、研究機構、顧問公司、中小企業和大型企業都很有用且經濟實惠。

企業使用我們的報告的目的是什麼？

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

• 2021年至2025年的實際數據和2026年至2031年的預測數據
• 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
• 競爭定位、策略和市場佔有率分析
• 按業務板塊和地區分類的收入和預測評估，包括國家/地區
• 公司概況（策略、產品、財務資訊、關鍵發展等）

目錄

第1章執行摘要

第2章 市場概覽

• 市場概覽
• 市場定義
• 調查範圍
• 市場區隔

第3章 商業情境

• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析
• 產業價值鏈分析
• 政策與法規
• 策略建議

第4章 技術展望

第5章 全球遠距手術市場（按類型分類）

• 介紹
• 機器人系統
• 儀器和配件
• 其他

6. 全球遠距手術市場（按應用分類）

• 介紹
• 婦科手術
• 泌尿系統手術
• 整形外科手術
• 心血管外科
• 神經外科
• 胃腸外科手術
• 其他

7. 按最終用戶分類的全球遠端手術市場

• 介紹
• 醫院
• 門診手術中心
• 研究所
• 其他

8.按地區分類的全球遠距手術市場

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

第9章：競爭格局與分析

• 主要企業和策略分析
• 市佔率分析
• 合併、收購、協議和合作
• 競爭對手儀錶板

第10章：公司簡介

• Intuitive Surgical, Inc.
• Stryker Corporation
• Medtronic plc
• Zimmer Biomet Holdings, Inc.
• Johnson & Johnson Services, Inc.
• Smith & Nephew plc
• TransEnterix Surgical, Inc.
• Verb Surgical Inc.（a joint venture between Verily Life Sciences and Johnson & Johnson）
• Medrobotics Corporation
• Titan Medical Inc.

第11章附錄

• 貨幣
• 先決條件
• 基準年和預測年時間表
• 相關人員的主要收益
• 調查方法
• 簡稱

The global remote surgery market, with a 16.64% CAGR, is anticipated to reach USD 36.558 billion in 2031 from USD 14.521 billion in 2025.

The global remote surgery market represents the convergence of advanced robotics, telecommunications, and surgical science, creating a paradigm shift in how complex procedures are delivered. This market is experiencing significant expansion, driven by a persistent demand for surgical innovation, the imperative to democratize access to specialist care, and substantial technological maturation. Remote surgery, also referred to as telesurgery or teleoperated surgery, utilizes sophisticated robotic systems and high-fidelity communication networks to enable surgeons to perform minimally invasive procedures on patients located at a physical distance.

Core Market Dynamics and Primary Growth Drivers

The market's growth is propelled by several powerful, interrelated forces. Foremost is the increasing demand for minimally invasive procedures across surgical specialties. Patients and providers alike seek the benefits of smaller incisions, reduced trauma, diminished scarring, shorter hospital stays, and faster recovery times. Remote surgical platforms, predominantly robotic-assisted systems, are inherently designed to facilitate this approach, offering the enhanced precision, dexterity, and visualization required for complex minimally invasive techniques that can be challenging with traditional laparoscopy.

This is closely linked to the growing acceptance and proven clinical validation of robotic-assisted surgery. Surgeons and healthcare institutions increasingly recognize the technological advantages in terms of procedural accuracy, tremor filtration, and improved ergonomics. As clinical evidence demonstrating positive patient outcomes accumulates, the adoption barrier lowers, fostering a receptive environment for next-generation telesurgery platforms that build upon this established foundation.

Furthermore, rising global investments in advanced healthcare infrastructure are creating the necessary ecosystem for adoption. The deployment of remote surgery systems requires not only capital investment in the technology itself but also robust digital infrastructure, including high-bandwidth, low-latency communication networks and integrated hospital information systems. Strategic investments in modernizing surgical suites and telecommunications capabilities are critical enablers for market penetration.

A compelling driver is the potential for transformative efficiency and access in healthcare delivery. Remote surgery holds the promise of overcoming geographical barriers, allowing world-class surgical expertise to be delivered to patients in rural, remote, or underserved areas without the need for travel. This can optimize the utilization of scarce surgical specialists, reduce systemic delays in care, and potentially generate significant cost savings for healthcare systems by centralizing expertise and streamlining patient pathways.

Market Segmentation and Competitive Landscape

The market is segmented by component type, application, end-user, and geography. Key segments include the robotic systems themselves (the capital equipment), the associated instruments and accessories, and supporting software and services. End-users are primarily large hospitals and academic medical centers, with growing potential in ambulatory surgical centers.

The competitive landscape is characterized by a mix of established medical robotics leaders and innovative entrants. Intuitive Surgical Inc., with its da Vinci Surgical System, holds a historically dominant position, having pioneered and validated the market for robotic-assisted minimally invasive surgery. Other major medical technology companies, such as Medtronic with its Hugo platform and Zimmer Biomet with its ROSA systems, are advancing competitive platforms with specific focuses on general surgery and orthopedics/neurosurgery, respectively. Research institutions and technology developers like SRI International contribute to foundational innovation, exploring next-generation telesurgery concepts. Competition centers on technological differentiation, procedural versatility, cost-effectiveness, and the depth of clinical training and support ecosystems.

Geographical Outlook: North American Leadership

North America maintains a leadership position in the global remote surgery market. This dominance is attributed to a confluence of structural advantages: a concentration of leading market players and research institutions, a well-developed healthcare infrastructure with high technological adoption rates, substantial healthcare expenditure, and a reimbursement environment that, while complex, has established pathways for advanced surgical technologies. The region's focus on surgical innovation and early adoption of new medical devices solidifies its role as the primary market and a testing ground for next-generation systems.

Future Trajectory and Strategic Implications

The remote surgery market is poised for continued evolution beyond its current state, which is largely defined by robotic-assisted surgery within a single operating room. The future trajectory points toward true long-distance telesurgery, enabled by ultra-reliable, low-latency communication networks (e.g., 5G and beyond). This will necessitate advancements in haptic feedback, enhanced artificial intelligence for decision support and safety, and robust cybersecurity protocols.

For industry participants, strategic success will depend on demonstrating not only superior clinical outcomes but also compelling economic value through improved operational efficiency and expanded patient reach. Navigating rigorous regulatory pathways for true remote operations, establishing standardized training and credentialing protocols, and ensuring seamless system integration within existing hospital workflows will be critical challenges. As the technology transitions from an advanced tool to a networked care delivery platform, remote surgery is set to redefine the boundaries of surgical practice, making specialized, high-quality intervention more accessible and efficient on a global scale.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Remote Surgery Market Segmentation

• By Type
• Robotic Systems
• Instruments and Accessories
• Others
• By Application
• Gynecology Surgery
• Urology Surgery
• Orthopedic Surgery
• Cardiovascular Surgery
• Neurology Surgery
• Gastrointestinal Surgery
• Others
• By End-User
• Hospitals
• Ambulatory Surgical Centers
• Research Institutes
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL REMOTE SURGERY MARKET BY TYPE

• 5.1. Introduction
• 5.2. Robotic Systems
• 5.3. Instruments and Accessories
• 5.4. Others

6. GLOBAL REMOTE SURGERY MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Gynecology Surgery
• 6.3. Urology Surgery
• 6.4. Orthopedic Surgery
• 6.5. Cardiovascular Surgery
• 6.6. Neurology Surgery
• 6.7. Gastrointestinal Surgery
• 6.8. Others

7. GLOBAL REMOTE SURGERY MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Ambulatory Surgical Centers
• 7.4. Research Institutes
• 7.5. Others

8. GLOBAL REMOTE SURGERY MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Intuitive Surgical, Inc.
• 10.2. Stryker Corporation
• 10.3. Medtronic plc
• 10.4. Zimmer Biomet Holdings, Inc.
• 10.5. Johnson & Johnson Services, Inc.
• 10.6. Smith & Nephew plc
• 10.7. TransEnterix Surgical, Inc.
• 10.8. Verb Surgical Inc. (a joint venture between Verily Life Sciences and Johnson & Johnson)
• 10.9. Medrobotics Corporation
• 10.10. Titan Medical Inc.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations